Initiation of mineralocorticoid receptor antagonists in patients with cardiorenal diseases: potassium changes, hyperkalaemia risk and discontinuation in the CaRe study
9 May 2026 (08:00 - 12:45)
Organised by: 
About the speaker
Duke Clinical Research Institute, Durham (United States of America)
5 More presentations in this session
Professor S. Greene (Durham, US)
Doctor B. Resende (Coimbra, PT)
Doctor R. Aggarwal (Boston, US)
Assistant Professor M. Ruppert (Boston, US)
Not all creatinine rises are kidney injury, early renal congestion phenotypes in acute heart failure
Mrs E. Vice (Atlanta, US)
Access the full session
The Event
Heart Failure 2026
9 May - 12 May 2026
You may be interested in
Congress Presentation
Congress Presentation
